These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12881374)

  • 1. Mammographic screening: case-control studies.
    Walter SD
    Ann Oncol; 2003 Aug; 14(8):1190-2. PubMed ID: 12881374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammographic screening: evidence from randomised controlled trials.
    de Koning HJ
    Ann Oncol; 2003 Aug; 14(8):1185-9. PubMed ID: 12881373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUSOMA review of mammography screening.
    Hackshaw A
    Ann Oncol; 2003 Aug; 14(8):1193-5. PubMed ID: 12881375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer screening.
    Jatoi I
    Am J Surg; 1999 Jun; 177(6):518-24. PubMed ID: 10414706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in screening with mammography.
    Larsson LG
    Acta Oncol; 1997; 36(7):675-9. PubMed ID: 9490082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammographic screening and mammographic patterns.
    Day N; Warren R
    Breast Cancer Res; 2000; 2(4):247-51. PubMed ID: 11250716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer screening by mammography in women aged under 50 years in Japan.
    Morimoto T; Sasa M; Yamaguchi T; Kondo H; Akaiwa H; Sagara Y
    Anticancer Res; 2000; 20(5C):3689-94. PubMed ID: 11268440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.
    Duffy SW; Tabar L; Vitak B; Yen MF; Warwick J; Smith RA; Chen HH
    Ann Oncol; 2003 Aug; 14(8):1196-8. PubMed ID: 12881376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.
    Frisell J; Lidbrink E; Hellström L; Rutqvist LE
    Breast Cancer Res Treat; 1997 Sep; 45(3):263-70. PubMed ID: 9386870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.
    Humphrey LL; Helfand M; Chan BK; Woolf SH
    Ann Intern Med; 2002 Sep; 137(5 Part 1):347-60. PubMed ID: 12204020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
    de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
    J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the UK breast screening programmes.
    Sasieni P
    Ann Oncol; 2003 Aug; 14(8):1206-8. PubMed ID: 12881379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of The Netherlands breast cancer screening programme.
    Verbeek AL; Broeders MJ; ;
    Ann Oncol; 2003 Aug; 14(8):1203-5. PubMed ID: 12881378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
    J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening programmes--results of studies in foreign countries--situation in Belgium.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 May; 2(3):269-74. PubMed ID: 8490549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. Trial Steering Group.
    Moss S
    J Med Screen; 1999; 6(3):144-8. PubMed ID: 10572845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
    MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
    Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.